HealthNews

Vaccine production: NAFDAC embarks on training

By Hassan Zaggi

In preparation to begin vaccine production in Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) has said that there is the need for training and retraining of staff because vaccine production is a lot of hard work.

Speaking when responding to questions from journalists after the formal launch of the 73 vehicles for use by NAFDAC  for its operations in Abuja, Thursday, the Director General of NAFDAC, Prof. Christian Adeyeye said: “Nigeria can now manufacture its own vaccine. NAFDAC only set guidelines. If a company want to manufacture vaccine, they come to us and we give them guidelines. It is very important and  very costly to do.

“One of the reality that we have to face is training. We have to train people, making vaccine is a lot of work they have to do. 

“The good thing is that we have the human capital. We have Veterinary Institute in Vom, they have been manufacturing animal vaccine for 75 years. They have the intellectual capacity. They will play a big role to support the human vaccine production.

“We have National Institute of Medical Research, we have National Institute of Pharmaceutical Research and Development (NIPRD), we have many in the country. In terms of capacity building, we just have to harvest and work with each other.”

Sachet, bottle water producers

She disclosed that NAFDAC has keen interest on producers of both sachet and bottle  water and that her agency is, on a daily basis, shutting down companies that are producing substandard water.

“We have interest in sachet and bottle water day and night. Everything that is going to make our people safe, healthier, yes.

“As we speak, we are shutting down water companies in Abuja, Lagos and different parts of the country. Companies that did not even register with us.

“You will be surprise to see the unhygienic surrounding of some water producers. We keep getting information about such and we keep shutting them down.

“If they register with us and they want to compromise their standard, we fine them big so that it will cost their pocket and they will think on how not to hurt our people by water that is not of quality.”

Responding to a questions on what preparation NAFDAC is doing to move to the maturity level 4 level of certification by the World Health Organisation (WHO), Prof. Adeyeye said: “Sincerely speaking, to get to Maturity level 4 will take at least one year. But before we announced the maturity 3 level, we already started working on maturity level 4. We are going to have our new vaccine building  completed.

“Apart from the maturity level 4, we are going to have a new vaccine lab.

Per centage of fake drugs in Nigeria

She, however, debunked the recent claim that over 70 per cent of drugs in Nigeria are substandard.

“There was a rumour somewhere that about 70 per cent of our drugs are not good. That is a lie. I can say 15 per cent because we are using risk-base sampling  of products that we know can be easily faked.

“As part of our maturity level consideration, we have to show them mechanism in place to go after products that can be easily faked and do a survey and then we get an idea of how much out there that may be fake. Around 13 to 15 per cent but we are going to be mitigating it.

“As we speak, our staff are working in uploading some tools on labtops and we are going to be using a device that cost about 57,000 dollars and we have 40 of them. We will be doing that because that is what they want to see.

“We are also doing track and trace to monitor supply chain, meaning from manufacturer to the users. It is a 5-year national strategy.  We are going that to make sure we mitigate substandard falsified medicines. But it is not something we do overnight.

“We are already engaging our local manufacturers to put back that track and trace in place so that we can monitor their own products from the manufacturer to the pharmacists that will dispense them. “

Related Posts

Leave a Comment

This News Site uses cookies to improve reading experience. We assume this is OK but if not, please do opt-out. Accept Read More